Original Article
You have full text access to this OnlineOpen article
Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis
Article first published online: 30 DEC 2003
DOI: 10.1053/jhep.2002.30084
Copyright © 2002 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Vogel, A., Strassburg, C. P. and Manns, M. P. (2002), Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology, 35: 126–131. doi: 10.1053/jhep.2002.30084
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 5 OCT 2001
- Manuscript Received: 14 MAY 2001
Funded by
- Deutsche Forschungsgemeinschaft. Grant Number: SFB244C11
References
- 1, , , , , , , et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929–938.MEDLINE
- 2
- 3, , , , , , . Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997; 112:2028–2035.MEDLINE
- 4, , , , , , . Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25:317–323.MEDLINE
- 5, , , , , . Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999; 117:645–652.MEDLINE
- 6, , , , , , . Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30:851–856.MEDLINE
- 7, , , . Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 1993; 104:1478–1484.MEDLINE
- 8, , , . Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31:49–53.MEDLINE
- 9, , , , , . Autoimmune regulator AIRE: Evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 2001; 33:1047–1052.MEDLINE
- 10, , , , , , , et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101:1367–1373.MEDLINE
- 11, , , , , , . CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32:538–541.MEDLINE
- 12, , , , , . HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48:397–402.MEDLINE
- 13, , , , , , . The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999; 30:826–829.MEDLINE
- 14, , , , , , , et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol 1999; 30:232–236.MEDLINE
- 15
- 16, , , , . Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983; 57:1308–1310.MEDLINE
- 17
- 18, , , . Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125:1704S–1708S.MEDLINE
- 19, , , . Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986; 59:333–338.MEDLINE
- 20, , , , , , , . 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000; 28:575–583.MEDLINE
- 21, , , , , , , . Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164:4443–4451.MEDLINE
- 22, , , , , , , et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101:252–262.MEDLINE
- 23
- 24, , , . Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 1989; 12:329–335.MEDLINE
- 25, , . Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987; 79:1659–1664.MEDLINE
- 26, , , , , , , et al. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999; 84:3739–3744.MEDLINE
- 27, , , , , , . Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1989; 69:127–133.MEDLINE
- 28, , , . 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 1998; 160:5314–5319.MEDLINE
- 29
- 30, , , , . Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994; 37:552–558.MEDLINE
- 31
- 32, , , , , , , et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995; 310:1357–1360.MEDLINE
- 33, , , , , , , et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res 1996; 11:1241–1248.MEDLINE
- 34, , , , , . Vitamin D receptor genotypes and bone mineral density. Lancet 1995; 345: 1238 [discussion 1239].
- 35, , , , . Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study. J Bone Miner Res 1996; 11:827–834.MEDLINE
- 36, , , , , , . Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49:504–507.MEDLINE
- 37, , , , , , , et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997; 40:971–975.MEDLINE
- 38, , , , , , , . Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf) 2000; 52:575–580.MEDLINE
- 39, . Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000; 85:4639–4643.MEDLINE
- 40, , . Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000; 10:475–480.MEDLINE
- 41, , , , , . Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 2000; 177:65–71.MEDLINE
- 42, , , , , , . Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999; 166:47–52.MEDLINE
- 43, , , , , , , et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118:145–151.MEDLINE
- 44, , , , . Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 1998; 13:31–35.MEDLINE
- 45, , , , . The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 1997; 12:1043–1048.MEDLINE
- 46, , , , , . The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11:1850–1855.MEDLINE
- 47, . Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000; 174:250–259.MEDLINE
- 48, , , , , . Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2. Am J Gastroenterol 1998; 93:1394–1395.MEDLINEDirect Link:
- 49, , , , , . HLA-C genes and susceptibility to type 1 autoimmune hepatitis. Hepatology 1997; 26:1023–1026.MEDLINE
- 50, , , , . HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 1995; 21:959–962.MEDLINE
- 51
- 52
- 53, , , , , , , et al. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 1997; 12:726–733.MEDLINE
- 54, , , , . Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem Biophys Res Commun 1997; 238:77–80.MEDLINE
- 55, , , , , , . Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 2000; 52:211–216.MEDLINE
- 56, , , , . Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 1999; 14:740–746.MEDLINE
- 57, , , . Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone 1996; 18:249–252.MEDLINE

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)